DOW CHEMICAL CO /DE/

NOTE 20 –SEGMENTS AND GEOGRAPHIC REGIONS

Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Loss before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

1. Significant expense categories are presented on an operating basis, net of the impact of significant items.

2. SARD includes selling, general and administrative and research and development expenses.

3. Other segment income (expense) items includes amortization of intangibles and sundry income (expense) - net.

4. Segment Operating EBIT for TDCC for the three months ended March 31, 2026 and 2025 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Loss before income taxes" is provided in the following table.

1. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.

1. See Note 9 for additional information regarding the Company's investments in nonconsolidated affiliates.

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

1. Includes costs to achieve of $53 million and severance and related benefit costs of $27 million associated with Transform to Outperform. See Note 4 for additional information related to severance and related benefit costs.

2. Implementation costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.

3. Loss due to change in fair value of the estimated liability associated with the Company's guarantee of Sadara's project financing debt. See Notes 9, 11 and 18 for additional information.

4. Related to a gain associated with a legal matter with Nova. See Note 11 for additional information.

1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 4 for additional information.

2. Severance and related benefit costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.

3. The Company retired outstanding long-term debt resulting in a loss on early extinguishment.

4. Includes charges related to an arbitration settlement agreement for historical product claims from a divested business.